Da'at Technologies

Da’at Technologies — High-level overview, origin, differentiators, role in tech landscape, and quick take.

Direct answer — Da’at Technologies appears to be a name used by multiple, distinct organizations (software engineering / digital transformation firms, a reputational intelligence platform, and a healthcare data AI startup formerly called Da’at AI) rather than a single, clearly defined company; available public sources describe at least three different entities using the “Da’at/Da’at” brand with different missions and products[1][3][4]. Below I summarize the most relevant profiles and synthesize what can be said about “Da’at” organizations while noting which facts map to which entity.

High‑Level Overview

• Daat Labs / Da’at Labs (software development & digital transformation): A technology services company that markets software engineering and digital-transformation services to mid‑sized businesses across industries such as healthcare, financial services and real‑estate; it emphasizes client-first engineering and using automation to reduce reliance on low-skilled labor[1].
  - DA`AT (reputational intelligence / stakeholder intelligence): A firm offering reputational and stakeholder intelligence platforms and custom engineering for institutions that need legislative monitoring, stakeholder profiling, and visualization dashboards for communications and public affairs teams[3].
  - Da’at (Da’at AI) — healthcare data & AI: A clinical‑data and AI startup co‑founded in 2019 that built a large connected molecular and clinical data library to support longitudinal, outcome‑based analytics; this team and technology were acquired by Tempus in an announced deal that placed Da’at’s founders and engineering team into Tempus’ organization[4].

For an investment firm: Not applicable — none of the indexed Da’at entities are primary investment firms in the sources found.

For a portfolio company: Not applicable — the sources describe operating companies and service/product firms rather than a portfolio holding.

Origin Story

• Daat Labs: Presented as founded by Bechor Mosheyev with CTO Samuel Bekker cited on the site; described as born to put clients first and to deliver cutting‑edge technologies to mid‑market customers[1].
  - DA`AT (reputational intelligence): Described as built by teams with 25 years of engineering experience at the intersection of communications, PR and public affairs; the site frames itself as a long‑standing engineering practice that evolved into purpose‑built intelligence products for stakeholder management[3].
  - Da’at AI (healthcare): Founded in 2019 by Ari Caroline and Iker Huerga (and colleagues) to create a clinical‑first information and learning model that enables longitudinal, outcome‑based contracts between employers and providers; Da’at built a large connected molecular and clinical dataset and was acquired by Tempus, which integrated the founders and team into its engineering and ML organization[4].

Core Differentiators

(organized by entity)

• Daat Labs (software services)[1]:
• Client‑first services model focused on mid‑sized business digital transformation[1].
  - Cross‑industry engineering experience (healthcare, finance, real estate) and emphasis on reducing dependence on low‑skilled outsourced labor[1].
  - Leadership with prior entrepreneurial and healthcare engineering experience (founder and CTO roles cited)[1].

• DA`AT reputational intelligence[3]:
• Purpose‑built intelligence for stakeholder, parliamentary and reputation management with real‑time alerts and AI summaries[3].
  - Quarter‑century engineering & domain experience bridging comms/PR and tech[3].
  - Custom data engineering and visualization offerings to embed intelligence into client workflows[3].

• Da’at AI (healthcare AI, now part of Tempus)[4]:
• Clinical‑first, longitudinal data model linking molecular and clinical records to produce real‑world evidence and support outcome‑based contracts[4].
  - Demonstrated data scale: described as “one of the world’s largest libraries of connected molecular and clinical data” prior to acquisition[4].
  - Founders with deep provider‑side analytics and ML experience at Memorial Sloan‑Kettering and similar institutions, giving strong clinical and engineering credibility[4].

Role in the Broader Tech Landscape

• Multiple “Da’at” entities ride adjacent trends rather than a single trend: digital transformation and outsourcing optimization (Daat Labs)[1], AI and data‑driven stakeholder intelligence for public affairs and reputation management (DA`AT)[3], and clinical/real‑world evidence, molecular + clinical data integration and healthcare AI (Da’at AI → Tempus)[4].
  - Timing & market forces:
• Demand for digital transformation and cost‑efficient engineering services remains strong among mid‑market firms, supporting Daat Labs’ positioning[1].
  - Heightened scrutiny of reputation, legislative change and stakeholder management drives demand for realtime intelligence and visualization in public affairs teams, supporting DA`AT’s product focus[3].
  - In healthcare, growing emphasis on real‑world evidence, longitudinal outcomes and molecular data integration makes clinical‑first datasets and models highly valuable; Da’at AI’s acquisition by Tempus reflects consolidation and the importance of scaled, linked clinical+molecular data for discovery and outcomes analytics[4].
  - Influence on ecosystem:
• Service and product offerings from the various Da’at entities appear oriented to enabling domain specialists (communications, providers, mid‑market businesses, researchers) to leverage data and engineering faster — a typical multiplier effect in their respective niches[1][3][4].

Quick Take & Future Outlook

• Daat Labs: Short‑term outlook depends on winning mid‑market digital transformation projects and demonstrating repeatable vertical use cases (healthcare, finance, real estate); scaling will require productization or partnerships to avoid purely projectized revenue[1].
  - DA`AT (reputational intelligence): Opportunity to grow as regulatory and reputational risks increase globally; continued product differentiation will depend on AI quality of summaries, data coverage, and integrations into comms workflows[3].
  - Da’at AI (healthcare, now at Tempus): Acquisition into Tempus suggests the team and technology will be scaled inside a larger data/AI healthcare platform, accelerating impact on real‑world evidence generation and longitudinal outcome models; expect integration into Tempus’ existing molecular and clinical data products and analytics pipelines[4].
  - Overarching: The repeated use of the Da’at/Da'at name across independent organizations means any investor, partner, or customer should verify which legal entity and offering they are engaging with and seek up‑to‑date corporate information (legal name, jurisdictions, and recent press) before proceeding.

Notes, limits, and sources

• Public sources show at least three distinct Da’at/Da’at‑branded organizations (Daat Labs site[1]; Da’at Consulting site[2] and DA`AT reputational intelligence[3]; and Da’at AI / acquisition coverage by Tempus[4]). Each bullet above is attributed to the corresponding source; if you want a single unified company profile, please confirm which specific Da’at entity (site or jurisdiction) you mean and I will build a focused profile with deeper research into filings, press, and leadership bios[1][3][4].